Bromodomain-Containing 4 Is a Positive Regulator of Interleukin-34 Production in the Gut
Cells · 2024
DOI: 10.3390/cells13201698 ↗Kurz gefasst
Fachartikel in der Zeitschrift Cells, 2024. Verfasst von Eleonora Franzè und 6 weiteren Autor:innen. Beteiligte Einrichtung: Department of Systems Medicine, University of Rome "TOR VERGATA", 00133 Rome, Italy. Hauptthemen laut MEDLINE: Interleukins, Transcription Factors, Colitis, Inflammatory Bowel Diseases. Die Arbeit wurde bisher 5-mal zitiert (Crossref) und nennt 28 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Ministero Dell' Università e della Ricerca, Italy, PRIN-2022 PNRR, PRIN HEAL ITALIA—PE6.
Abstract (Originalsprache)
Experimental evidence suggests that, in the inflamed gut of inflammatory bowel disease (IBD) patients, interleukin-34 (IL-34) triggers detrimental signaling pathways. Factors/mechanisms regulating IL-34 production in IBD remain poorly characterized. Bromodomain-containing 4 (BRD4), a transcriptional and epigenetic regulator, is over-expressed in IBD, and studies in cancer cells suggest that BRD4 might positively control IL-34 expression. This study aimed to assess whether, in IBD, BRD4 regulates IL-34 expression. In IBD, there was an up-regulation of both IL-34 and BRD4 compared to the controls, and the two proteins co-localized in both lamina propria mononuclear cells (LPMCs) and epithelial cells. Flow cytometry analysis of CD45+ LPMCs confirmed that the percentages of IL-34- and BRD4-co-expressing cells were significantly higher in IBD than in the controls and showed that more than 80% of the IL-34-positive CD45-LPMCs expressed BRD4. IL-34 and BRD4 were mainly expressed by T cells and macrophages. IL-34 expression was reduced in IBD LPMCs transfected with BRD4 antisense oligonucleotide and in the colons of mice with dextran sulfate sodium-induced colitis treated with JQ1, a pharmacological inhibitor of BRD4. These data indicate that BRD4 is a positive regulator of IL-34 in IBD, further supporting the pathogenic role of BRD4 in IBD-associated mucosal inflammation.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Systems Medicine, University of Rome "TOR VERGATA", 00133 Rome, Italy.
- Department of Systems Medicine, Policlinico Universitario Tor Vergata, 00133 Rome, Italy.
ORCID-Profile: Federica Laudisi, Carmine Stolfi, Giovanni Monteleone
Förderung
- Ministero Dell' Università e della Ricerca, Italy
- PRIN-2022 PNRR
- PRIN HEAL ITALIA—PE6
Zitieren
APA
Franzè, E., Laudisi, F., Frascatani, R., Tomassini, L., De Cristofaro, E., Stolfi, C., & Monteleone, G. (2024). Bromodomain-Containing 4 Is a Positive Regulator of Interleukin-34 Production in the Gut. Cells. https://doi.org/10.3390/cells13201698
Vancouver
Franzè E, Laudisi F, Frascatani R, Tomassini L, De Cristofaro E, Stolfi C, et al. Bromodomain-Containing 4 Is a Positive Regulator of Interleukin-34 Production in the Gut. Cells. 2024. doi:10.3390/cells13201698
BibTeX
@article{Franz2024,
author = {Franzè, Eleonora and Laudisi, Federica and Frascatani, Rachele and Tomassini, Lorenzo and De Cristofaro, Elena and Stolfi, Carmine and Monteleone, Giovanni},
title = {Bromodomain-Containing 4 Is a Positive Regulator of Interleukin-34 Production in the Gut},
journal = {Cells},
year = {2024},
doi = {10.3390/cells13201698}
}
EUVIMED